The department was founded in 1970. The main directions of research are:
- optimization of the methods of revascularization in patients with acute myocardial infarction through the increased efficiency of the antithrombotic therapy and cardioprotection from ischemic and reperfusive damage;
- development of a complex of methods for prevention and correction of the early post-infarction cardiac dila¬tion and development of heart failure;
- evaluation of the role of inflammatory process in patients with acute ischemic heart disease;
- substantiation of metabolic approaches to the treatment of patients with acute coronary syndromes and progressive heart failure;
- development of methods for the evaluation of myocardial viability in patients after the acute myocardial infarction;
- elaboration and introduction into practice of a complex of invasive and noninvasive procedures and criteria (electrophysiological, hemodynamic, neurohumoral) for identification of patients with high risk of development (or relapse) of life-threatening arrhythmias and sudden cardiac death;
The department has 18 beds and annually provides highly qualified medical service to more than 700 patients. The death rate is about 4,1%.
The modern methods of diagnostics and treatment are used at the department, such as endocardial transesopageal electrocardiostimulation, systemic thrombolysis, electroimpulse (DC) therapy, different resuscitation procedures. Some other techniques are carried out, such as invasive electrophysiological studies, Holter ECG-monitoring, sectoral echocardiography, stress echocardiography with dobutamine, loading tests, high resolution electrocardiography, catheterization of peripheral vessels, blood pressure measurement in pulmonary lung artery and right heart chambers and express-methods of biochemical investigation.
In the last 10 years 330 scientific works were published, including 150 abroad; 7 guidelines, 8 inventions were patented.